Mykyta Kachanov

About

Mykyta Kachanov is a urologic oncology researcher whose work centers on improving outcomes for prostate cancer patients undergoing robotic-assisted radical prostatectomy (RARP). His research focuses on the intersection of surgical technique, patient quality of life, and risk stratification. Kachanov’s most impactful study, with 18 citations, investigates how obesity affects perioperative, functional, and oncological results after RARP in a high-volume center—providing critical insights for tailoring surgical approaches to higher-risk populations. In another key contribution (9 citations), he assessed two-year quality of life changes using the EORTC QLQ-C30 instrument, correlating outcomes with the Cancer of the Prostate Risk Assessment (CAPRA-S) score and the pentafecta criteria. This work was among the first to explore meaningful QoL changes in men achieving optimal surgical outcomes, bridging the gap between clinical benchmarks and patient-reported well-being. Kachanov’s research helps surgeons and patients make more informed decisions by clarifying how comorbidities and risk profiles influence long-term recovery. His contributions are shaping evidence-based counseling in robotic prostate cancer surgery.

Research Focus

Key Achievements

Top Papers

1. 1
   Impact of obesity on perioperative, functional and oncological outcomes after robotic-assisted radical prostatectomy in a high-volume center

   18 citations · 2022
2. 2
   Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S)

   9 citations · 2022

Key Collaborators

Contact & Links